Cecal cancer revealing Muir-Torre syndrome with an MSH2 mutation

This colorectal cancer diagnosis at a glance

Subtype
Adenocarcinoma
Biomarkers
MSI-high; loss of MSH2 expression; truncating MSH2 mutation
Sex
female
Treatment
surgery and chemotherapy

Treatment course, step by step

  1. Underwent right hemicolectomy for the cecal cancer.
  2. Received adjuvant chemotherapy.

What happened, in summary

A woman with a history of recurrent sebaceous tumors and a strong family history of colorectal cancer underwent colonoscopy after clinicians suspected Muir-Torre syndrome. Although she had no gastrointestinal symptoms, a lesion was found in the cecum. She underwent right hemicolectomy followed by adjuvant chemotherapy. Pathology showed a well-differentiated adenocarcinoma with small mucinous areas and no lymph-node involvement. Molecular testing of the colon tumor showed high microsatellite instability and loss of MSH2 protein expression. Sequencing identified a truncating MSH2 mutation, supporting an inherited mismatch-repair syndrome. Her history also included endometrial cancer with ovarian metastases and multiple sebaceous neoplasms, fitting the broader Muir-Torre pattern. The colorectal diagnosis became an important part of recognizing the hereditary syndrome and the need for lifelong cancer surveillance and genetic counseling for the patient and family.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar colorectal cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more colorectal cancer stories